SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-24-006144
Filing Date
2024-02-29
Accepted
2024-02-29 17:23:27
Documents
90
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tgtx20231231_10k.htm   iXBRL 10-K 2200581
2 EXHIBIT 10.38 ex_631839.htm EX-10.38 523726
3 EXHIBIT 19.1 ex_632901.htm EX-19.1 110715
4 EXHIBIT 21.1 ex_579420.htm EX-21.1 3634
5 EXHIBIT 23.1 ex_579421.htm EX-23.1 2474
6 EXHIBIT 31.1 ex_579423.htm EX-31.1 12341
7 EXHIBIT 31.2 ex_579424.htm EX-31.2 12682
8 EXHIBIT 32.1 ex_579425.htm EX-32.1 5690
9 EXHIBIT 32.2 ex_579426.htm EX-32.2 6037
10 EXHIBIT 97.1 ex_632982.htm EX-97.1 60484
16 picture1small.jpg GRAPHIC 108402
17 tglogo01.jpg GRAPHIC 6596
  Complete submission text file 0001437749-24-006144.txt   10192286

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20231231.xsd EX-101.SCH 74979
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20231231_cal.xml EX-101.CAL 46634
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20231231_def.xml EX-101.DEF 514319
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20231231_lab.xml EX-101.LAB 468937
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20231231_pre.xml EX-101.PRE 550902
92 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20231231_10k_htm.xml XML 1393055
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32639 | Film No.: 24705218
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)